The Bloodborne Pathogen Standard is an
occupational safety and health standard that prevents occupational
exposure to bloodborne pathogens. The standard's information
collection requirements are essential components that protect
workers from occupational exposure. The information is used by
employers and workers to implement the protection required by the
Standard. OSHA compliance officers will use some of the information
in their enforcement of the Standard.
US Code:
29
USC 657 Name of Law: Occupational Safety and Health Act
US Code: 29
USC 651 Name of Law: Occupational Safety and Health Act
US Code: 29
USC 655 Name of Law: Occupational Safety and Health Act
The Agency is requesting an
adjustment decrease in the number of burden hours from 14,518,778
to 5,528,742 hours (a decrease of 8,990,036 hours). The Agency
updated the industry profile and estimates that the number of
facilities and employees affected by the Standard has increased.
However, the Agency calculates an overall decrease in burden hours.
This is primarily related to an administrative error found in the
previous ICR which overestimated the burden hours and costs related
to health care professional time associated with the Hepatitis B
vaccination. Also, part of the decrease in burden hours is related
to the determination that the training provision of the Standard,
although still in effect, is not considered to be a collection of
information. The operation and maintenance cost increased from
$34,342,534 to $46,093,897 due to the increase in medical costs
(administration of the Hepatitis B Vaccine and HIV antibody tests,
and the PEP treatment). The industry profile was updated using the
2011 County Business Patterns where OSHA's sectors, originally
based on the 1997 County Business Patterns and 1987 SIC, could be
reasonably represented by a selection of 2007 NAICS industries. For
government entities, the 2011 Quarterly Census of Employment and
Wages was used where 2007 NAICS industries could reasonably
represent the original industry sectors. This resulted in an
increase in affected facilities from 666,933 to 691,669. The agency
increased employment relative to the change in the number of
affected facilities resulting in an increase of affected employees
from 7,551,260 to 8,720,108. The updated industry profile
contributed to changes in the number of burden hours and total
costs of the exposure control plan, Hepatitis B vaccination and
post-exposure evaluation and follow-up, and recordkeeping
requirements in Item 12. For Item 13, updates to the industry
profile contributed to changes to Tables 3 and 4 (the costs for the
administration of the Hepatitis B Vaccine and HIV antibody tests).
Other causes contributing to changes to Item 12 burden hours and
costs include adding rounding to the calculations in various tables
and corrections to some administrative errors in the calculations
in the tables in the Appendix. One key correction was to Table 3
which counted the Item 13 costs of the vaccinations as burden
hours. This adjustment resulted in a decrease of roughly 6 million
burden hours. The Agency updated the cost of PEP treatment using
the 2013 VA Pharmaceutical Drug Pricing resulting in a change in
the cost per employee from $1,601 to $2,843. Corrections to the
calculations in Tables 4 cont, 8, and 10 caused the changes for the
administration of HBV source tests, HBV antibody tests for
non-vaccinated workers, and HBIG tests for vaccinated workers.
Usually, OSHA will request access to records during compliance
inspections. Information collected by the Agency during the
investigation is not subject to the PRA under 5 CFR 1320.4(a)(2).
Therefore, OSHA takes no burden or cost in Items 12 and 14 of this
Supporting Statement
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.
Final SS_1218-0180_031315.doc
FED20141007A.pdf
Bloodborne Pathogens Standard (29 CFR 1910.1030)